Kristen Sanfilippo/X
Jun 22, 2025, 12:53
Kristen Sanfilippo: Time to Anticoagulants Therapy is a Modifiable Risk Factor for PE-associated Mortality
Kristen Sanfilippo, Hematologist in the Division of Hematology at Washington University School of Medicine, shared a post on X:
“Time to Anticoagulants therapy is a modifiable risk factor for PE-associated mortality.
- Big weekend for Kelsey Bria
- Finished Residency
- Started Fellowship as our newest ASH HFFTP
- First Oral “
More posts from ISTH 2025 on Hemostasis Today.
-
Jun 1, 2026, 11:16Ocima Richard Draza: Postpartum Hemorrhage – A Practical Step-by-Step Management Guide
-
Jun 1, 2026, 10:57Kyungjun Lim: How Will Future Mars Colonies Manage Their Supply Chains?
-
May 31, 2026, 16:29José Antonio García Erce: Collaborative PBM Implementation in Transfusion Centers and Services
-
May 31, 2026, 16:22Vera Ignjatović: How Do We Rigorously Study These Drugs in Children to Understand Their True Benefits and Risks?
-
May 31, 2026, 16:21Ksenija Stach: Is This The Future of Lipid-Lowering Lherapy?
-
May 31, 2026, 15:42Antonio Greco: Balancing Bleeding and Thrombotic Risk After PCI
-
May 31, 2026, 15:41Eric Topol: Replication of Plasma p-tau217 Blood Test for Predicting Alzheimer’s Disease
-
May 31, 2026, 15:32ASH Invites Dynamic Members to Apply for 2027 Leadership and Committee Roles
-
May 31, 2026, 14:39Monique Gore-Massy: Redefining Lupus Innovation Through Patient Partnership